Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

Type II Diabetes I: Introduction

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...

Carbohydrate Metabolism

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...

Diabetes: Symptoms, Diagnosis, and Complications

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Prolactinoma-associated headache: Clinical and radiological correlates and long-term outcomes.

Pituitary·2026

Same author

68Ga-DOTA-exendin-4 PET/CT for Insulinoma Localization in Patients with Negative or Inconclusive Conventional Imaging.

The Journal of clinical endocrinology and metabolism·2026

Same author

Evolution of thyroid surgery: unravelling complications from the 1930s to the modern era - a retrospective cohort study.

Swiss medical weekly·2026

Same author

Increased progression free survival with radiolabelled somatostatin receptor antagonist versus standard peptide receptor radionuclide therapy in patients with somatostatin receptor positive tumours.

European journal of nuclear medicine and molecular imaging·2026

Same author

Class III Obesity as a Presenting Syndrome in Prolactinoma Patients: Insights Into Obesity and Metabolic Dysfunction in This Unique Group.

Clinical obesity·2026

Same author

Targeted β<sup>-</sup>-Particle Plus Conversion and Auger-Electron Therapy with <sup>161</sup>Tb-Labeled Somatostatin Receptor Antagonist DOTA-LM3: A Phase 0 Study.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2025

Search research articles

Related Experiment Video

Updated: Jun 19, 2026

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People

Published on: July 5, 2017

[Type 2 diabetes among elderly people].

Daniel Noth¹, Rahel Sahli, Petra Elsässer Imboden

¹Universitätspoliklinik für Endokrinologie, Diabetologie und Klinische Ernährung, Inselspital, Universität Bern.

Therapeutische Umschau. Revue Therapeutique

|October 16, 2009

Summary

Managing type 2 diabetes in older adults requires individualized HbA1c targets around 7.0%. Insulin therapy is key for symptomatic cases, prioritizing hypoglycemia prevention and overall health.

Related Experiment Videos

Last Updated: Jun 19, 2026

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People

Published on: July 5, 2017

Area of Science:

Geriatric Medicine
Endocrinology
Metabolic Disorders

Context:

Type 2 Diabetes Mellitus (T2DM) is prevalent in elderly populations.
Older adults (>70 years) often have reduced life expectancy and multiple comorbidities.
Effective T2DM management in this demographic requires tailored approaches.

Purpose:

To define appropriate glycemic targets for elderly patients with T2DM.
To outline therapeutic strategies considering comorbidities and patient well-being.
To emphasize the role of insulin and lifestyle modifications in managing T2DM in the elderly.

Summary:

Recommended HbA1c targets for elderly patients (>70 years or <10 years life expectancy) are around 7.0% (max 8%).
For patients with multiple comorbidities, focus on symptom improvement and preserving muscle mass.
Insulin is the preferred treatment for uncontrolled, symptomatic T2DM with catabolism, emphasizing hypoglycemia prevention.
Balanced nutrition and regular food intake are crucial for improving quality of life.
Cardiovascular risk factor management should be individualized based on overall health status.

Impact:

Provides evidence-based guidelines for optimizing T2DM care in the elderly.
Aims to improve patient outcomes by preventing complications and enhancing quality of life.
Highlights the importance of personalized treatment strategies in geriatric diabetes management.